GeneDx announced on May 7, 2025, the successful completion of its acquisition of Fabric Genomics, a pioneer in AI-powered genomic interpretation. This acquisition marks a significant step in GeneDx's strategy to integrate genomic insights into standard healthcare globally.
The combination of GeneDx’s industry-leading exome and genome testing and rare disease data asset with Fabric Genomics’ advanced AI interpretation services establishes a new ecosystem for genomic diagnostics. This integrated model offers greater flexibility for providers and health systems, supporting both centralized and decentralized genomic services.
Fabric Genomics will operate independently as a subsidiary of GeneDx, benefiting from GeneDx's commercial support. This acquisition is expected to accelerate key growth opportunities, including NICU market penetration, genomic newborn screening, and global commercial expansion through Fabric Genomics' cloud-native platform.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.